473 related articles for article (PubMed ID: 18282629)
1. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
2. Effect of acidic pH on PLGA microsphere degradation and release.
Zolnik BS; Burgess DJ
J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
Hickey T; Kreutzer D; Burgess DJ; Moussy F
J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
[TBL] [Abstract][Full Text] [Related]
4. Elevated temperature accelerated release testing of PLGA microspheres.
Zolnik BS; Leary PE; Burgess DJ
J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
6. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
7. PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation.
Bhardwaj U; Sura R; Papadimitrakopoulos F; Burgess DJ
Int J Pharm; 2010 Jan; 384(1-2):78-86. PubMed ID: 19800956
[TBL] [Abstract][Full Text] [Related]
8. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
9. An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots.
Deadman CM; Kellaway IW; Yasin M; Dickinson PA; Murdan S
J Control Release; 2007 Sep; 122(1):79-85. PubMed ID: 17638603
[TBL] [Abstract][Full Text] [Related]
10. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
12. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
Rawat A; Burgess DJ
Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
[TBL] [Abstract][Full Text] [Related]
13. In situ fiber optic method for long-term in vitro release testing of microspheres.
Voisine JM; Zolnik BS; Burgess DJ
Int J Pharm; 2008 May; 356(1-2):206-11. PubMed ID: 18329196
[TBL] [Abstract][Full Text] [Related]
14. Drug release from PLGA microspheres attached to solids using supercritical CO₂.
Mulia K; Witkamp GJ; Dawes GJ; Fratila-Apachitei LE; Apachitei I; Duszczyk J; Pellikaan H
J Biomater Appl; 2011 Jan; 25(5):401-12. PubMed ID: 20042430
[TBL] [Abstract][Full Text] [Related]
15. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
[TBL] [Abstract][Full Text] [Related]
16. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.
Patil SD; Papadmitrakopoulos F; Burgess DJ
J Control Release; 2007 Jan; 117(1):68-79. PubMed ID: 17169457
[TBL] [Abstract][Full Text] [Related]
17. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
18. Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig.
Kastellorizios M; Tipnis N; Papadimitrakopoulos F; Burgess DJ
Mol Pharm; 2015 Sep; 12(9):3332-8. PubMed ID: 26237140
[TBL] [Abstract][Full Text] [Related]
19. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
20. PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics.
Habraken WJ; Wolke JG; Mikos AG; Jansen JA
J Biomater Sci Polym Ed; 2008; 19(9):1171-88. PubMed ID: 18727859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
